Northwest Biotherapeutics Inc (NASDAQ:NWBO)

7.38
Delayed Data
As of 11:19am ET
 -0.08 / -1.07%
Today’s Change
3.79
Today|||52-Week Range
9.35
+37.94%
Year-to-Date

Today’s Trading

Previous close7.46
Today’s open7.49
Day’s range7.29 - 7.49
Volume126,320
Average volume (3 months)559,409
Market cap$471.7M
Dividend yield--
Data as of 11:19am ET, 03/31/2015

Growth & Valuation

Earnings growth (last year)+65.03%
Earnings growth (this year)+8.50%
Earnings growth (next 5 years)+10.00%
Revenue growth (last year)+4.79%
P/E ratioNM
Price/Sales153.15
Price/Book--

Competitors

 Today’s
change
Today’s
% change
IGIGI Laboratories Inc-0.19-2.25%
MRTXMirati Therapeutics ...-0.04-0.14%
RVNCRevance Therapeutics...+1.06+5.40%
XNPTXenoport Inc-0.04-0.55%
Data as of 11:33am ET, 03/31/2015

Financials

Last reporting dateMarch 30, 2015
EPS forecast (this quarter)-$0.33
Annual revenue (last year)$809.0K
Annual profit (last year)-$65.8M
Net profit margin-8,132.14%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President, CEO, CFO &
CAO
Linda F. Powers
Chief Scientific Officer, Secretary &
Director
Alton L. Boynton
Corporate headquarters
Bethesda, Maryland

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account